MyFinsight
Home
About
Contact
wgs: the income statement
Download
Download image
Comprehensive loss
-$7,445K
(5.20%↑ Y/Y)
Unrealized gain related to
available for sale...
$190K
(-58.61%↓ Y/Y)
Legacy Sema4
$1,717K
Gene Dx
$1,503K
Legacy Sema4
$329K
Gene Dx
$113,194K
Net loss
-$7,635K
(8.14%↑ Y/Y)
Product And Service
Other
$3,220K
Diagnostic Test
$113,523K
Income tax (expense)
benefit
$247K
(625.53%↑ Y/Y)
Loss before income
taxes
-$7,388K
(11.62%↑ Y/Y)
Total revenue
$116,743K
(51.86%↑ Y/Y)
Total non-operating
expense, net
-$4,137K
(-614.51%↓ Y/Y)
Loss (income) from
operations
-$3,251K
(58.21%↑ Y/Y)
Gross profit
$84,527K
(76.73%↑ Y/Y)
Cost of services
$32,216K
(10.92%↑ Y/Y)
Other (expense)
income, net
-$174K
(-115.21%↓ Y/Y)
Interest expense, net
-$562K
(33.33%↑ Y/Y)
Change in fair value of
financial liabilities
-$3,401K
(-286.48%↓ Y/Y)
General and
administrative
$44,439K
(69.97%↑ Y/Y)
Selling and marketing
$23,510K
(38.09%↑ Y/Y)
Research and development
$19,829K
(69.99%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. (WGS)